EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Markers of refractory primary immune thrombocytopenia

Guillaume Moulis iD, Lamya Garabet iD

British Journal of Haematology · 2023-10 · 203 (1) · 112-118

DOI: 10.1111/bjh.19076 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift British Journal of Haematology, online erschienen am 30.08.2023. Verfasst von Guillaume Moulis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Referral Center for Autoimmune Cytopenia, Toulouse University Hospital, Toulouse, France. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Refractory immune thrombocytopenia (ITP) is a challenging disease that can be defined by refractoriness to second‐line treatments. In this review, we list and comment available evidence about clinical and biological factors associated with refractoriness to splenectomy, thrombopoietin receptor agonists (TPO‐RAs), rituximab and fostamatinib, as well as those associated with multirefractory ITP (active disease with failure of rituximab, TPO‐RAs and splenectomy).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purpura, Thrombocytopenic, IdiopathicHumansReceptors, FcReceptors, ThrombopoietinRecombinant Fusion ProteinsRituximabSplenectomyThrombopoietinBiomarkers

Stichwörter der Autor:innen

markersrefractory primary immune thrombocytopeniathrombopoietin receptor

Substanzen

Receptors, FcReceptors, ThrombopoietinRecombinant Fusion ProteinsRituximabThrombopoietinBiomarkers

Autor:innen und Institutionen

  • Department of Internal Medicine, Referral Center for Autoimmune Cytopenia, Toulouse University Hospital, Toulouse, France.
  • Clinical Investigation Center 1436, Team PEPSS, Toulouse University Hospital, Toulouse, France.
  • Center for Laboratory Medicine, Østfold Hospital Trust, Grålum, Norway.

ORCID-Profile: Guillaume Moulis, Lamya Garabet

Zitieren

APA

Moulis, G., & Garabet, L. (2023). Markers of refractory primary immune thrombocytopenia. British Journal of Haematology, 203(1), 112-118. https://doi.org/10.1111/bjh.19076

Vancouver

Moulis G, Garabet L. Markers of refractory primary immune thrombocytopenia. British Journal of Haematology. 2023;203(1):112-118. doi:10.1111/bjh.19076

BibTeX
@article{Moulis2023,
  author = {Moulis, Guillaume and Garabet, Lamya},
  title = {Markers of refractory primary immune thrombocytopenia},
  journal = {British Journal of Haematology},
  year = {2023},
  volume = {203},
  number = {1},
  pages = {112--118},
  doi = {10.1111/bjh.19076}
}
Kostenlos starten →